MicroRNA-320a: an important regulator in the fibrotic process in interstitial lung disease of systemic sclerosis - Li, Yiqun; Huang, Jing; Hu, Chaojun; Zhou, Jiaxin; Xu, Dong; Hou, Yong; Wu, Chanyuan; Zhao, Jiuliang; Li, Mengtao; Zeng, Xiaofeng; Liu, Changzheng; Wang, Qian; et al. (Arthritis research & therapy, 2021)
Keywords: Antibodies; Anticoagulants; Arthritis; Binding sites; Care and treatment; Collagen; Collagen Type I; Fibroblasts; Fibrosis; Genes; Health aspects; Humans; IGF-1; Interstitial lung disease; Lung diseases; Lung Diseases, Interstitial - genetics; Medical research; MicroRNA; MicroRNAs; MicroRNAs - genetics; miR-320a; Mutation; Pathogenesis; Properties; Quality control; Rheumatism; Scleroderma; Scleroderma (Disease); Scleroderma, Systemic - genetics; Systemic scleroderma; Systemic sclerosis; TGF-β; China; United States--US; Japan; TGF-β; IGF-1; miR-320a; Interstitial lung disease; Systemic sclerosis